Fiber-rich maltooligosaccharides having low glucose bioavailability, method of manufacture thereof and use thereof in human food and animal feed

Abstract

The present invention relates to maltooligosaccharides, the content of -1,4-glycosidic bonds of which is between 70% and 80% of the total number of 1,4-type glycosidic bonds. The invention also relates to the method for manufacturing these maltooligosaccharides. Said maltooligosaccharides afford all the benefits of fiber-based foods, with an extremely low nutritional value. Such a compromise is particularly advantageous for use in healthy balanced diets, but also in the treatment and/or prevention of the pathology of diabetes. The invention also relates to the use of said maltooligosaccharides in the fields of human food and animal feed.

Claims

1. A method for manufacturing maltooligosaccharides having a content of -1,4-bonds of between 65% and 83% of the total number of 1,4-glycosidic bonds a ratio of the total number of 1,4-glycosidic bonds to the total number of 1,6-glycosidic bonds of greater than 1 and lower to 2.50 and a content of -1,6-bonds of between 35% and 58% of the total number of 1,6-glycosidic bonds, comprising the steps consisting of: a) providing an aqueous solution of at least two carbohydrates, characterized in that 40% to 95% of the dry weight of said solution consists of maltose, b) placing the aqueous solution resulting from step a) in contact with at least one polyol and at least one inorganic or organic acid, c) optionally increasing the solids content of the aqueous solution resulting from step b) up to at least 75% by weight of the total weight thereof, and d) carrying out a heat treatment on the aqueous solution resulting from step b) or optionally from step c), at a temperature of between 140 C. and 300 C. under a negative pressure of between 50 and 500 mbar.

2. The method as claimed in claim 1, characterized in that the aqueous solution resulting from step a) contains glucose.

3. The method as claimed in claim 1, characterized in that the aqueous solution resulting from step a) has a solids content of at least 50% by weight of the total weight thereof.

4. The method as claimed in claim 1, characterized in that the polyol is selected from glycerol, erythritol, xylitol, arabitol, ribitol, sorbitol, dulcitol, mannitol, maltitol, isomaltitol, lactitol and mixtures thereof.

5. The method as claimed in claim 1, characterized in that, when the acid is organic, it is selected from citric, sulfuric, fumaric, succinic, gluconic and hydrochloric acid and mixtures of these acids.

6. The method as claimed in claim 1, characterized in that step c) is carried out in the form of a heat treatment at a temperature of between 60 C. and 150 C.

7. The method as claimed in claim 6, characterized in that step c) is carried out under a negative pressure of between 50 mbar and 500 mbar.

8. The method as claimed in claim 1, characterized in that step d) is carried out at between 150 C. and 200 C.

9. The method as claimed in claim 8, characterized in that step d) is carried out at a pressure of between 50 mbar and 500 mbar.

10. Maltooligosaccharides obtained according to the method of claim 1.

11. The maltooligosaccharides as claimed in claim 10, characterized in that they have a fiber content of between 50% and 70%.

12. The maltooligosaccharides as claimed in claim 10, characterized in that they have an amount of glucose released or accessible after enzymatic digestion of between 1% and 12%.

13. Maltooligosaccharides having a content of -1,4-bonds of between 65% and 83% of the total number of 1,4-glycosidic bonds, a ratio of the total number of 1,4-glycosidic bonds to the total number of 1,6-glycosidic bonds of greater than 1 and lower than 2.50 and a content of -1,6-bonds of between 35% and 58% of the total number of 1,6-glycosidic bonds.

14. The maltooligosaccharides as claimed in claim 13, characterized in that they have a content of -1,6-bonds of between 38% and 52% of the total number of 1,6-glycosidic bonds.

15. The maltooligosaccharides as claimed in claim 13, characterized in that they have a fiber content of between 50% and 70%.

16. The maltooligosaccharides as claimed in claim 13, characterized in that they have an amount of glucose released or accessible after enzymatic digestion of between 1% and 12%.

17. A food composition comprising the maltooligosaccharides of claim 10.

18. The food composition of claim 17, wherein the food composition is a human food.

19. The food composition of claim 17, wherein the food composition is an animal feed.

20. The maltooligosaccharides as claimed in claim 10, characterized in that they have a content of -1,4-bonds of between 70% and 80% of the total number of 1,4-glycosidic bonds.

21. The maltooligosaccharides as claimed in claim 13, characterized in that they have a content of -1,4-bonds of between 70% and 80% of the total number of 1,4-glycosidic bonds.

Description

BRIEF DESCRIPTION OF THE DRAWING

(1) FIG. 1 shows signal integration and limits of integration.

(2) FIG. 2 shows results of products not according to the invention.

DETAILED DESCRIPTION OF THE INVENTION

(3) A first subject of the invention is based on a method for manufacturing maltooligosaccharides comprising the steps consisting in: a) providing an aqueous solution of at least two carbohydrates, characterized in that 40% to 95% of the dry weight of said solution consists of maltose, b) placing the aqueous solution resulting from step a) in contact with at least one polyol and at least one inorganic or organic acid, c) optionally increasing the solids content of the aqueous solution resulting from step b) up to at least 75% by weight of the total weight thereof, d) carrying out a heat treatment on the aqueous solution resulting from step b) or optionally from step c), at a temperature of between 130 C. and 300 C. under a negative pressure of between 50 and 500 mbar.

(4) The first step of the method according to the invention consists in providing an aqueous solution of carbohydrates, of which 40% to 95% of the dry weight thereof consists of maltose.

(5) Preferably, the other carbohydrates are saccharide compounds of glucose. These carbohydrates may thus be provided in the form of one or more glucose syrups.

(6) According to one quite particularly preferred variant of the invention, said aqueous solution resulting from step a) also contains glucose.

(7) In this step, the maltose and the other carbohydrates may be supplied in the form of dry products (powders) or alternatively in liquid form. When dry products are used, it is appropriate to add water to them so as to produce the aqueous solution which is the subject of step a). The liquid form is referred to as syrup and consists of an aqueous solution of at least one carbohydrate. A preferred variant of the invention consists in mixing a syrup containing at least one carbohydrate and at least one carbohydrate in the form of dry product. According to this variant, mixing is facilitated if the temperature is brought to at least 50 C. and at most 90 C.

(8) The aqueous solution resulting from step a) has a solids content of at least 50%, preferably of at least 70%, very preferably of at least 80% by weight of the total weight thereof, and in any case of at most 95% by weight of the total weight thereof.

(9) A particularly preferred syrup of at least one carbohydrate is one in which the distribution of the degrees of polymerization (D.sub.P) is as follows: from 1% to 5% compounds having a degree of polymerization of 1 from 40% to 75% compounds having a degree of polymerization of 2 from 10% to 25% compounds having a degree of polymerization of 3 from 5% to 10% compounds having a degree of polymerization between 4 and 8 inclusive from 1% to 15% compounds having a degree of polymerization between 9 and 20 inclusive from 1% to 15% compounds having a degree of polymerization of strictly greater than 20

(10) each of these % being expressed as % of the total weight of the carbohydrates contained in said syrup, and the sum of these % being equal to 100%.

(11) Among the most preferred syrups, mention may be made of the syrup sold by the applicant company under the name Glucose Syrup 5774, the distribution of the degrees of polymerization of which corresponds to the ranges listed above.

(12) Another particularly preferred syrup of at least one carbohydrate is one in which the distribution of the degrees of polymerization (D.sub.P) is as follows: from 8% to 30% compounds having a degree of polymerization of 1 from 40% to 75% compounds having a degree of polymerization of 2 from 7% to 17% compounds having a degree of polymerization of 3 from 3% to 10% compounds having a degree of polymerization between 4 and 8 inclusive from 0.1% to 5% compounds having a degree of polymerization between 9 and 20 inclusive from 0.1% to 5% compounds having a degree of polymerization of strictly greater than 20

(13) each of these % being expressed as % of the total weight of the carbohydrates contained in said syrup, and the sum of these % being equal to 100%.

(14) This other syrup may especially be obtained by mixing the glucose syrup 5774 with dextrose in powder form.

(15) The second step of the method according to the invention consists in placing the aqueous carbohydrate solution described above in contact with at least one polyol and at least one inorganic or organic acid. Mixing is facilitated if the temperature of the medium is brought to at least 50 C. and at most 90 C.

(16) The polyol used in the method in accordance with the invention may especially be selected, without however this selection being exhaustive, from glycerol, erythritol, xylitol, arabitol, ribitol, sorbitol, dulcitol, mannitol, maltitol, isomaltitol, lactitol and mixtures thereof, more preferably from sorbitol, mannitol and maltitol, the most preferred polyol being maltitol. The polyol represents 5% to 30%, preferably 5% to 25%, very preferably 5% to 10% by weight of the sum of the dry weights of carbohydrates, of said polyol and of the acid.

(17) The polyol is introduced in the form of an aqueous solution, with a solids content of between 20% and 90%, preferably between 25% and 85%, and very preferably between 30% and 80% by weight of the total weight thereof. Alternatively, the polyol may initially be present in anhydrous form, and in this case it may be dissolved directly by introduction into the syrup containing at least one carbohydrate, or it may be placed in aqueous solution beforehand by being dissolved in water.

(18) The method in accordance with the present invention also employs an inorganic or organic acid, preferably organic, as catalyst for the polymerization reaction. This organic acid may be selected, non-exhaustively, from citric, sulfuric, fumaric, succinic, gluconic and hydrochloric acid and mixtures of these acids, citric acid being the most preferred.

(19) In any case, the acid selected should not be too volatile, and should not be incompatible with, or pose potential risks to, future use in the fields of human food and animal feed.

(20) The amount of acid employed here is between 0.5% and 2%, preferably between 0.5% and 1.5%, and is very preferably approximately 1% by weight of said acid relative to the dry weight of carbohydrates, of the polyol and of said acid. In any case, those skilled in the art will know to adapt the amount of acid employed, especially taking into consideration questions of subsequent neutralization linked to the use of any excess of said acid. The acid in question can be used in the form of an aqueous solution, with a solids content of between 20% and 90%, preferably between 25% and 85%, and very preferably between 30% and 80% by weight of the total weight thereof. Alternatively, said acid may initially be present in anhydrous form, and in this case it may be dissolved directly by introduction into the carbohydrate syrup, or it may be placed in aqueous solution beforehand by being dissolved in water.

(21) Preferably, those skilled in the art employing the method according to the present invention will seek to obtain a solids content for the reaction medium including the mixture of carbohydrates, the polyol and the acid of between 20% and 98%, preferably between 25% and 95%, and very preferably between 30% and 95% by weight of the total weight thereof. Those skilled in the art will know to adapt this solids content, especially as a function of the richness desired for the reaction medium but also, inter alia, taking account of the vicosity of the medium (with regard to any problems of pumpability and/or transfer of the resulting medium). They will also know to adapt it with a view to limiting, or even avoiding if they so wish, the optional step c) consisting in increasing the solids content of the aqueous solution containing the carbohydrates, the polyol and the acid up to at least 75% by dry weight.

(22) The third step of the method according to the invention is optional since it consists, where appropriate, in increasing the solids content of the aqueous solution resulting from step b) up to at least 75% by weight of the total weight thereof. This is carried out in the form of a heat treatment, especially at a temperature of between 60 C. and 150 C., preferably between 80 C. and 120 C. Preferably, a negative pressure of between 50 mbar and 500 mbar, preferably between 100 mbar and 400 mbar, will be applied. The duration of this step is between 4 and 20 hours. Those skilled in the art will know to adapt the parameters of time, temperature and pressure, especially as a function of the initial solids content thereof and of the solids content which they desire to finally obtain. For those skilled in the art, the term apply a negative pressure means that the pressure indicated is less than 1 bar absolute pressure, unlike the term apply a pressure which means that the pressure is greater than atmospheric pressure. In other words, when a negative pressure of between X mbar and Y mbar is applied, this means that the absolute pressure is between X mbar and Y mbar.

(23) The fourth step of the method according to the invention consists in carrying out a heat treatment on the aqueous solution resulting from step b) or optionally from step c), at a temperature of between 130 C. and 300 C. under a negative pressure of between 50 and 500 mbar. The polymerization reaction occurs under these conditions.

(24) This step is carried out in a polymerization reactor fitted with heating devices and which makes it possible to work at reduced pressure. Such a reactor may especially consist of a curing oven or a vacuum furnace. Alternatively, the operation of adjusting the solids content and of polymerization is carried out in the same reactor, which advantageously has the abovementioned means and devices.

(25) The polymerization reaction is carried out at a temperature of between 130 C. and 300 C., preferably between 150 C. and 200 C. The water generated by the reaction is avacuated continuously by evaporation. This operation is carried out under reduced pressure, especially at a negative pressure of between 50 mbar and 500 mbar. In parallel, said reaction is carried out for a time of between 5 minutes and 4 hours, preferably between 5 minutes and 2 hours.

(26) The reaction temperature and time are interdependent variables. It is advisable to ensure that the temperature is not raised too high, so as to avoid any pyrolysis and/or heat degradation phenomena of the products (since such a degradation may adversely affect the sensory properties of the final food product manufactured). Nonetheless, the reaction time decreases as much as the temperature increases, with a view to complete polymerization. From this point of view, the products according to the present invention may just as well be manufactured at a temperature of the order of 250 C. and with a residence time of 10 minutes, as at a temperature of approximately 180 C. and a residence time of approximately 90 minutes. Using the method of the invention, those skilled in the art may vary the -1,4-bond content of the total number of 1,4-glycosidic bonds in the following way; the further the reaction progresses, the more this content decreases.

(27) A second subject of the present invention consists of maltooligosaccharides able to be obtained according to the method defined above.

(28) According to a first embodiment, these maltooligosaccharides have a content of -1,4-bonds of between 70% and 80% of the total number of 1,4-glycosidic bonds. According to a second embodiment, these maltooligosaccharides have a content of -1,4-bonds of between 65% and 83% of the total number of 1,4-glycosidic bonds and/or a ratio of the total number of 1,4-glycosidic bonds to the total number of 1,6-glycosidic bonds of greater than 1 and/or a content of -1,6-bonds of between 35% and 58% of the total number of 1,6-glycosidic bonds.

(29) Another subject of the present invention consists of maltooligosaccharides having, according to a first embodiment, a content of -1,4-bonds of between 70% and 80% of the total number of 1,4-glycosidic bonds. According to a second embodiment, these maltooligosaccharides have a content of -1,4-bonds of between 65% and 83% of the total number of 1,4-glycosidic bonds and/or a ratio of the total number of 1,4-glycosidic bonds to the total number of 1,6-glycosidic bonds of greater than 1 and/or a content of -1,6-bonds of between 35% and 58% of the total number of 1,6-glycosidic bonds.

(30) These maltooligosaccharides which are subjects of the present invention may also be characterized in that they have a content of -1,6-bonds of between 35% and 58% of the total number of 1,6-glycosidic bonds, advantageously between 38% and 52% of the total number of 1,6-glycosidic bonds, preferably between 40% and 50% of the total number of 1,6-glycosidic bonds.

(31) These maltooligosaccharides may also be characterized in that they have a fiber content of between 50% and 70%.

(32) These maltooligosaccharides are also characterized in that they have an amount of glucose released or accessible after enzymatic digestion of between 1% and 12%, more preferably of between 3% and 9%.

(33) According to this second embodiment, the maltooligosaccharides may have a content of -1,4-bonds of between 65% and 80% of the total number of 1,4-glycosidic bonds, especially of between 65% and 70% of the total number of 1,4-glycosidic bonds.

(34) The maltooligosaccharides of the first embodiment may, like that of the second embodiment, a ratio of the total number of 1,4-glycosidic bonds to the total number of 1,6-glycosidic bonds of greater than 1. Preferably, the maltooligosaccharides of the invention have a ratio of the total number of 1,4-bonds to the total number of 1,6-bonds ranging from 1.03 to 2.50 and for example from 1.05 to 2.

(35) A final subject of the present invention relates to the use of the maltooligosaccharides according to the invention, or able to be obtained according to the method defined above, in human food and animal feed.

(36) Non-limitingly, the maltooligosaccharides according to the invention, or able to be obtained according to the method defined above, may be incorporated into compositions or products intended for ingestion and for oral administration, such as various foodstuffs, for instance confectionery, pastries, ice creams, chewing pastes, chewing gums, drinks, jellies, soups, milk-based preparations, yoghurts, cakes, prepared animal fodder, dietary supplements, pharmaceutical, veterinary, dietary or hygiene products, such as, for example, elixirs, cough syrups, lozenges or tablets, pastilles, oral hygiene solutions, toothpastes and tooth gels.

(37) Maltooligosaccharides of the second embodiment and variants of these maltooligosaccharides:

Embodiment A

(38) Maltooligosaccharides having a content of -1,4-bonds of between 65% and 83% of the total number of 1,4-glycosidic bonds, a ratio of the total number of 1,4-glycosidic bonds to the total number of 1,6-glycosidic bonds of greater than 1 and a content of -1,6-bonds of between 35% and 58% of the total number of 1,6-glycosidic bonds.

Embodiment B

(39) Maltooligosaccharides according to embodiment A, also having a ratio of the total number of 1,4-glycosidic bonds to the total number of 1,6-glycosidic bonds ranging from 1.03 to 2.50, for example from 1.05 to 2.

Embodiment C

(40) Maltooligosaccharides according to embodiment A or B, also having a content of -1,6-bonds of between 38% and 52% of the total number of 1,6-glycosidic bonds, preferably between 40% and 50% of the total number of 1,6-glycosidic bonds.

Embodiment D

(41) Maltooligosaccharides according to one of embodiments A to C, also having a content of -1,4-bonds of between 65% and 80% of the total number of 1,4-glycosidic bonds.

Embodiment E

(42) Maltooligosaccharides having a content of -1,4-bonds of between 65% and 80% of the total number of 1,4-glycosidic bonds and a ratio of the total number of 1,4-glycosidic bonds to the total number of 1,6-glycosidic bonds of greater than 1.

Embodiment F

(43) Maltooligosaccharides according to embodiment E, also having a content of -1,6-bonds of between 35% and 58% of the total number of 1,6-glycosidic bonds, advantageously between 38% and 52% of the total number of 1,6-glycosidic bonds, preferably between 40% and 50% of the total number of 1,6-glycosidic bonds.

Embodiment G

(44) Maltooligosaccharides according to one of embodiments E and F, also having a ratio of the total number of 1,4-glycosidic bonds to the total number of 1,6-glycosidic bonds ranging from 1.03 to 2.50, for example from 1.05 to 2.

Embodiment H

(45) Maltooligosaccharides having a content of -1,4-bonds of between 65% and 83% of the total number of 1,4-glycosidic bonds and a content of -1,6-bonds of between 35% and 52% of the total number of 1,6-glycosidic bonds.

Embodiment I

(46) Maltooligosaccharides according to embodiment H, also having a ratio of the total number of 1,4-glycosidic bonds to the total number of 1,6-glycosidic bonds of greater than 1, advantageously ranging from 1.03 to 2.50, for example from 1.05 to 2.

Embodiment J

(47) Maltooligosaccharides according to embodiment H or I, also having a content of -1,6-bonds of between 38% and 52% of the total number of 1,6-glycosidic bonds, preferably between 40% and 50% of the total number of 1,6-glycosidic bonds.

Embodiment K

(48) Maltooligosaccharides according to one of embodiments H to J, also having a content of -1,4-bonds of between 65% and 80% of the total number of 1,4-glycosidic bonds.

Embodiment L

(49) Maltooligosaccharides according to one of embodiments A to K, also having a fiber content of between 50% and 70%.

Embodiment M

(50) Maltooligosaccharides according to one of embodiments A to L, also having a content of -1,4-bonds of between 65% and 70% of the total number of 1,4-glycosidic bonds.

Embodiment N

(51) Maltooligosaccharides according to one of embodiments A to M, also having an amount of glucose released or accessible after enzymatic digestion of between 1% and 12%, more preferably of between 3% and 9%.

(52) The examples which follow make it possible to better understand the present invention, without however limiting the scope thereof.

Examples

Experimental Methods

(53) Throughout the present application, the contents of glycosidic bonds are determined by NMR, and by the Hakomori method.

(54) NMR makes it possible to access the proportions of -1,4- and -1,6-bonds on the one hand, and the other glycosidic bonds on the other.

(55) The Hakomori method makes it possible to access the contents of total 1,4-, 1,6-, 1,2- and 1,3-glycosidic bonds.

(56) Regarding NMR, an Avance III Fourier transform spectrometer (Bruker Spectrospin) operating at 400 MHz and 60 C. and using 5 mm NMR tubes is used. More generally speaking, it is possible to use any other Fourier transform spectrometer, as long as said spectrometer is fitted with all the accessories enabling the production and utlization of a proton spectrum, and also with an accessory which makes it possible to work at temperatures greater than room temperature. Deuterated water, or D.sub.2O (min. 99%), from Euriso Top (CEA Group, Gif-sur-Yvette, France), and sodium salt of 3-trimethylsilyl-1-propanesulfonic acid or TSPSA (Aldrich, ref. 178837) are used.

(57) The procedure for the experiments is as follows: Introduce 10 mg of sample and 0.75 ml of D.sub.2O into an NMR tube. Seal the tube, mix, then place in a water bath. After dissolution, remove the tube from the water bath and let it cool to room temperature. Add 50 l of a 10 mg/g solution of TSPSA in D.sub.2O. Adjust the spinner on the tube and place everything in the magnet. Carry out acquisition, without solvent suppression, with a relaxation time of at least 10 s and without rotation, following suitable instrument settings (field, lock phase and shims). Use a spectral window of between at least 0.1 ppm and 9 ppm, referring to the signal for the methyls of the TSPSA calibrated to 0 ppm.

(58) Use is made of the spectrum after Fourier transformation, phase correction and subtraction of the base line in manual mode (without exponential multiplication; LB=GB=0). Use is made of the results in the following manner: Integrating the signals; reference may especially be made to figure 1/2 for the limits of integration. Standardizing the signal S5 to 600, this signal corresponding to the non-exchangeable protons of an anhydroglucose unit (H.sub.2, H.sub.3, H.sub.4, H.sub.5 and 2H.sub.6); the rest of the signal corresponding to all the H.sub.1 protons (reducing end groups and bonds). Taking the values of S1 (H.sub.1 (1,4), S2 (H.sub.1 reducing ) and S3 (H.sub.1 (1,6)). Determining the S4 -reducers by performing the operation S20.6/0.4. Calculating S6 by performing the operation S6=100(S1+S2+S3+S4). Determining the proportions of -(1,4)-, -(1,6)- and other bonds by calculating the sum of the 3 respective surface areas (S1, S3 and S6) and by standardizing them to 100 to express them in % (i.e. % i=Si100/(S1+S3+S6)).

(59) TABLE-US-00001 TABLE 1 Integrated Limits of integration surface area (in ppm) Types of bonds S1 5.45 5.26 H.sub.1 -(1,4) S2 5.26 5.19 H.sub.1 -reducers S3 5.04 4.88 H.sub.1 -(1,6) S5 4.32 3.10 Other protons (H.sub.2, H.sub.3, H.sub.4, etc.) i.e. 6 protons

(60) The Hakomori method is that described in the 1964 publication J. Biol. Chem., 55, 205.

(61) Throughout the present application, the amount of glucose released or accessible after enzymatic digestion is determined according to the following method: Weigh out 0.3 g dry weight of product to be tested. Add 75 ml of 0.1 mol/l Na maleate buffer, pH 7.00 (Fluka, reference 63180). Stir until the product dissolves. Place the flasks in a water bath for 15 minutes, so that the temperature of the solution is 37 C. Take a sample of 0.75 ml of the initial solution and add 0.075 g of porcine pancreatin (Sigma, reference P7545) following the sampling of the initial solution; this operation corresponds to the start of timing. Incubate at 37 C. in a thermostated bath with stirring for 30 minutes. Take a sample of 0.75 ml. Add 0.40 g of rat intestinal mucosa (Sigma, reference 11630). Incubate for 3 h 30 at 37 C. in a thermostated bath with stirring. Over the course of these 3 h 30, take samples of 0.75 ml at 60, 120, 180 and 240 minutes. Stop the enzymatic reaction by placing the samples taken in a dry bath at 100 C. for 10 minutes. Carry out a glucose assay on the samples taken (GOD standard enzymatic method). Calculate the amount of glucose released during digestion of the product after the 3 h 30 (expressed in %): glucose concentration in g/l of the sample taken(100/product solids)volume of digest in ml/1000)(100/weight of wet product in g).

(62) Throughout the present application, the fiber content is measured according to AOAC method 2001-03.

(63) Products According to the Invention

(64) In tests nos. 1 to 5, 5 products were produced according to the method in accordance with the present invention.

(65) A glucose syrup 5774 (Flolys D57), sold by Roquette, with 85% solids content, is used.

(66) This syrup is diluted to 50 Bx.

(67) 1 kilo of material is prepared with the weight % mentioned in the table below, in a glass beaker. Said beaker is placed on a hotplate with stirring using a magnetic stirrer bar set to 500 rpm, the temperature being set to 60 C.

(68) Once this temperature has been reached, the glucose sold under the name Dextrose Anhydre C [Anhydrous Dextrose C] by Roquette is added in powder form to the beaker.

(69) The following products are then added in powder form to this aqueous solution: the maltitol sold under the name SweetPearl P200 by Roquette the citric acid sold by Sigma, with a purity of greater than or equal to 99.5%.

(70) The weight % of the constituents are given in table 2 for tests nos. 1, 2, 3, 4 and 5 which represent the invention.

(71) TABLE-US-00002 TABLE 2 Test No. 1 2 3 4 5 Flolys D57 81 68 68 72 71 (85% solids) Glucose 9 22.2 22.2 18 18 Maltitol 9 8.9 8.9 9 9 Citric acid 1 0.9 0.9 1 2

(72) After complete dissolution of the powders, i.e. after a few minutes, the mixture is clear.

(73) A sample of 120 grams of the mixture is then taken and transferred to an aluminum tray sold by Pro-Jet under reference KPL1001.

(74) The trays are placed in a vacuum furnace for 20 hours at 80 C. then 6 hours at 120 C. A negative pressure of 125 mbar is applied in the furnace. 95.0% solids is then obtained.

(75) The trays with the dry product are then placed in a second furnace heated beforehand to 200 C., everything being placed under a negative pressure of 125 mbar. The trays are removed 90 minutes later. The product is then diluted with water to 30% solids.

(76) For each of the 5 tests above, the applicant determined: the % of -1,4-glycosidic bonds of the total number of 1,4-glycosidic bonds the % of -1,6-glycosidic bonds of the total number of 1,6-glycosidic bonds the ratio of the total number of 1,4-glycosidic bonds to the total number of 1,6-glycosidic bonds the fiber content in % the amount of glucose released in %.

(77) Products not According to the Invention

(78) The applicant also determined these same parameters for the following products: NUTRIOSE FB06 sold by the applicant company (test no. 4) NUTRIOSE FB10 sold by the applicant company (test no. 5) LITESSE ULTRA sold by Dupont Danisco (test no. 6) PROMITOR 70 sold by Tate & Lyle (test no. 7) PROMITOR 85 sold by Tate & Lyle (test no. 8) FIBERSOL-2 sold by Matsutani (test no. 9) IMO 500 sold by (test no. 10)

(79) All the results have been given in table 3 and on figure 2/2, except for MOS 4 and MOS 5.

(80) TABLE-US-00003 TABLE 3 -1,4 -1,6 1,4-/1,6- Fibers Glucose Product (%) (%) ratio (%) (%) LITESSE 67 53 0.61 81 MALTOOLIGOSACCHARIDE 72 40 2.11 58 6 1 (MOS 1) MALTOOLIGOSACCHARIDE 78 43 1.37 55 4 2 (MOS 2) MALTOOLIGOSACCHARIDE 72 42 1.10 60 8 3 (MOS 3) MALTOOLIGOSACCHARIDE 66 42 1.45 65 4 (MOS 4) MALTOOLIGOSACCHARIDE 81 56 1.40 62 5 (MOS 5) NUTRIOSE FB06 85 52 2.06 83 20 NUTRIOSE FB10 86 44 1.75 74 22 PROMITOR 85 88 60 1.15 76 15 PROMITOR 70 90 50 1.73 60 34 FIBERSOL-2 82 70 2.11 90 13 IMO 500 100 95 1.34 0 100

(81) It is possible to observe, remarkably, that all the fiber-rich commercial products belonging to the prior art have a content of -1,4-glycosidic bonds of greater than 80%, with this content being within a very restricted range of between 80% and 90%.

(82) Moreover, all these products have a fiber content of at least 60%, in most cases at least 75%, and an amount of available glucose which is systematically greater than 10%, in most cases greater than 15% and even sometimes greater than 20%.

(83) Conversely, the 5 products according to the invention have a content of -1,4-glycosidic bonds of between 66% and 81%. It is observed that, particularly advantageously, these products have high fiber-richness, since said richness is at around 60%. Finally, 3 products according to the invention have a very low content of available glucose, at levels never before achieved. This is particularly surprising due to the fact that although these novel products are fiber-rich, they have a lower content of these fibers than the other products tested. Thus, only these products have the ideal compromise between a product that is relatively fiber-rich and therefore perfectly suited to healthy balanced diets, and a product with a very low glucose bioavailibility with regard to the organism and therefore perfectly suited to diabetic patients or those following diets aiming to reduce sensitivity to this pathological condition.